LANCET RHEUMATOL - Lancet Rheumatology
Publications
- 2023
Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study
Papp, K., Warren, R. B., Green, L., Reich, K., Langley, R. G., Paul, C., Asahina, A., Johnson, L., Arora, V., Osuntokun, O. & Lebwohl, M., 09.2023, In: LANCET RHEUMATOL. 5, 9, p. e542-e552Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial
Strand, V., Jayne, D. R. W., Horomanski, A., Yue, H., Bekker, P., Merkel, P. A. & ADVOCATE Study Group, 08.2023, In: LANCET RHEUMATOL. 5, 8, p. e451-e460 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review